Glatiramer Subcutaneous and Insulin degludec Subcutaneous
Determining the interaction of Glatiramer Subcutaneous and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Insulin detemir
- Glatiramer Subcutaneous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Glatiramer Subcutaneous-Insulin Detemir (Vials)
- Glatiramer Subcutaneous-Insulin detemir Subcutaneous
- Glatiramer Subcutaneous-Insulin glargine
- Glatiramer Subcutaneous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Glatopa
- Insulin degludec Subcutaneous-Glatopa injection
- Insulin degludec Subcutaneous-Glecaprevir and pibrentasvir
- Insulin degludec Subcutaneous-Gleevec
- Insulin degludec Subcutaneous-Glenmax PEB DM
- Insulin degludec Subcutaneous-Glenmax PEB DM FORTE